If you've just received your 23andMe results and seen "MTHFR C677T" flagged, you're not alone — and you're probably confused. The internet is full of either alarming misinformation or dismissive reassurance. Neither is useful. Here's what the peer-reviewed literature actually says.
What is MTHFR?
MTHFR stands for methylenetetrahydrofolate reductase — an enzyme that plays a central role in your methylation cycle. Specifically, it converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF), which is the active form of folate your body uses to recycle homocysteine into methionine.
The C677T variant (rs1801133) reduces this enzyme's activity. Heterozygous carriers (one copy, AG) see roughly 35–40% reduced activity. Homozygous carriers (two copies, AA) see 60–70% reduced activity.
Heterozygous (AG): One copy — moderate impact. Methylation is suboptimal but not severely impaired.
Homozygous (AA): Two copies — significant impact. Methylation cycle may be substantially compromised without intervention.
Why does this matter?
Impaired MTHFR activity has downstream consequences across several systems. The most clinically significant is elevated homocysteine — an amino acid that accumulates when the methylation cycle slows. Elevated homocysteine is associated with cardiovascular risk, cognitive decline, and neural tube defects in pregnancy.
Beyond homocysteine, impaired methylation affects neurotransmitter synthesis (dopamine, serotonin), DNA repair, detoxification, and gene expression regulation. This is why MTHFR variants are associated with a wide range of symptoms — brain fog, mood instability, fatigue, poor sleep — rather than one specific condition.
Important context: MTHFR is common. Roughly 40% of the population carries at least one copy of C677T. Having this variant doesn't mean you're ill — it means your methylation needs more support than average.
What to do — the evidence-based protocol
The primary intervention is simple: stop relying on folic acid and switch to active methylfolate. Your MTHFR enzyme can't efficiently convert folic acid to 5-MTHF — so standard supplements and fortified foods are largely ineffective, and high-dose folic acid may even be counterproductive by competing with the active form at receptor sites.
Core protocol for C677T carriers
1. Methylfolate (5-MTHF) — 400–800mcg/day. This bypasses the MTHFR enzyme entirely. Start at 400mcg. If you also carry COMT Met/Met, go slow — some people experience anxiety at higher doses. Thorne 5-MTHF and Seeking Health Optimal Folate are well-sourced options.
2. Methylcobalamin (B12) — 1000mcg/day. The methylation cycle requires B12 as a cofactor. Methylcobalamin is the active form — avoid cyanocobalamin. Sublingual absorption is superior to capsule for many people.
3. Riboflavin (B2) — 100mg/day. MTHFR is a flavoprotein — its activity depends on riboflavin as a cofactor. Studies show riboflavin supplementation meaningfully improves MTHFR function, particularly in homozygous carriers.
4. Test your homocysteine. This is non-negotiable. A baseline homocysteine test (available through most GP surgeries or private labs) tells you whether your methylation is actually impaired in practice. Target: below 7 µmol/L. Retest after 3 months of supplementation.
If you also carry COMT variants
COMT (catechol-O-methyltransferase) uses methyl groups to break down catecholamines like dopamine and adrenaline. If your COMT is slow (Met/Met), pushing methylation aggressively can flood your system with methyl groups and cause anxiety, irritability, or insomnia. Start with 400mcg methylfolate maximum and introduce changes slowly. A Genova Lab report maps both variants and gives you a calibrated protocol for your specific combination.
Bottom line: MTHFR C677T is manageable. The intervention is inexpensive, well-evidenced, and effective. The key is using the right forms at the right doses — which depends on your full variant picture, not just this one SNP.
References: Frosst et al. (1995) Nature Genetics 11:122; Wilcken et al. (2004) NEJM 350:2263; McNulty et al. (2006) Am J Clin Nutr 83:1043. This article is for educational purposes and does not constitute medical advice.